Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011742-26Phase 4Completed
Phase 4, open-label trial of tetanus, diphtheria, pertussis and poliomyelitis vaccine in Tetanus, diphtheria, pertussis and 1 more (2 cohorts), sponsored by Institute for Biomedical Aging Research. Primary endpoint: Humoral and cellular immune response at 28 days. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011742-26.